The prognostic importance of isolated tumor cell clusters and micrometastases in sentinel lymph nodes

Cancer Investigation

Volumn 27, Issue 2, 2009, Pages 121-128

  Weaver, Donald L ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TAMOXIFEN;

BIOLOGY; BREAST CANCER; CANCER DIAGNOSIS; CELL ISOLATION; DIAGNOSTIC PROCEDURE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MICROMETASTASIS; MICROSCOPY; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE; TUMOR CELL; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 60849112298     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802572029     Document Type: Review

References (26)

1. Nemoto, T.; Vana, J.; Bedwani, R.N.; et al. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980, 45, 2917-2924.
2. Huvos, A.G.; Hutter, R.V.P.; Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971, 173, 44-46.
3. Greene, F.L.; Page, D.L.; Fleming, I.D.; et al. Breast AJCC Cancer Staging Manual. 6th ed. New York: Springer, 2002.
4. Sobin, L.H.; Wittekind, Ch, eds. UICC TNM Classification of Malignant Tumours. 6th ed. New York: John Wiley and Sons, 2002.
5. Singletary, S.E.; Greene, F.L.; Sobin, L.H. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer 2003, 98, 2740-2741.
6. Al-Hajj, M.; Wicha, M.S.; Benito-Hernandez, A.; Morrison, S.J.; Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100, 3547-3549.
7. Dontu, G.; Al-Hajj, M.; Abdallah, W.M.; Clarke, M.F.; Wicha, M.S. Stem cells in normal breast development and breast cancer. Cell Prolif 2003, 36(1), 59-72.
8. Braun, S.; Cevatli, B.S.; Assemi, C.; et al. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of nodenegative breast cancer patients receiving no adjuvant therapy. J Clin Oncol 2001, 19, 1468-1475.
9. Fitzgibbons, P.L.; Page, D.L; Weaver, D.; et al. Prognostic factors in breast cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000, 124, 966-978.
10. Lyman, G.H.; Giuliano, A.E.; Somerfield, M.R.; et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005, 23(30), 7703-7720.
11. Weaver, D.L. Sentinel lymph nodes and breast carcinoma: which micrometastases are clinically significant? Am J Surg Pathol 2003, 27, 842-845.
12. Carter, C.L.; Allen, C.; Henson, D. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989, 63, 181-187.
13. Fisher, E.; Palekar, A.; Rockette, H.; Redmond, C.; Fisher, B. Pathologic findings from the national surgical adjuvant breast project (Protocol No. 4): V. significance of axillary nodal micro-and macrometastases. Cancer 1978, 42, 2032-2038.
14. Weaver, D.L. Pathological evaluation of sentinel lymph nodes in breast cancer: a practical academic perspective from America. Histopathology 2005, 46, 702-706.
15. Carter, B.A.; Jensen, R.A.; Simpson, J.F.; Page, D.L. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 2000, 113, 259-265.
16. Moore, K.H.; Thaler, H.T.; Tan, L.K.; Borgen, P.I.; Cody, H.S. III. Immunohistochemically detected tumor cells in the sentinel lymph nodes of patents with breast carcinoma: biologic metastasis or procedural artifact? Cancer 2004, 100, 929-934.
17. Hansen, N.M.; Ye, X.; Grube, B.J.; Giuliano, A.E. Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. Arch Surg 2004, 139, 634-640.
18. Lara, J.F.; Young, S.M.; Velilla, R.E.; Santoro, E.J.; Templeton, S.F. The relevance of occult axillary micrometastases in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. Cancer 2003, 98, 2105-2113.
19. Michaelson, J.S.; Silverstein, M.; Sgroi, D.; et al. The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer 2003, 98, 2133-2143.
20. Weaver, D.L.; Krag, D.N.; Ashikaga, T.; Harlow, S.P.; O'Connell, M. Pathologic analysis of sentinel and non-sentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 2000, 88, 1099-1107.
21. Hermanek, P.; Hutter, R.V.; Sobin, L.H.; Wittekind, C. International Union against cancer. classification of isolated tumor cells and micrometastasis. Cancer 1999, 86, 2668-2673.
22. Saphir, O.; Amromin, G.D. Obscure axillary lymph node metastases in carcinoma of the breast. Cancer 1948, 1, 238-241.
23. Dowlatshahi, K.; Fan, M.; Snider, H.C.; Habib, F.A. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997, 80, 1188-1197.
24. Krag, D.N.; Julian, T.B.; Harlow, S.P.; et al. NSABP-32: phase III randomized trial comparing axillary resection with sentinel lymph node dissection: a description of the trial. Ann Surg Oncol 2004, 11(3), 208s-210s.
25. Harlow, S.P.; Krag, D.N.; Julian, T.B.; et al. Prerandomization surgical training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg 2005, 241, 48-54.
26. Cserni, G.; Amendoeira, I.; Apostolikas, N.; et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey of the European Working Group for Breast Screening Pathology. J Clin Pathol 2004, 57, 695-701.